You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening. Financial terms of the deal were not disclosed.
NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.
By Adam Bonislawski
Two papers published in the current edition of Nature Biotechnology add significantly to the publicly available data on the specificity of kinase inhibitors.
Starting in the first quarter of 2011, DiscoveRx plans to add its own panel of cell-based assays to the KinomeScan service as an offering.
The co-marketing agreement will give Jubilant’s drug developer customers cell-based screening services.
BioFocus will offer DiscoveRx's GPCR and cAMP assays as part of its screening services.
DiscoveRx will provide GSK with access to its beta-arresting parental cell lines, clones, and associated reagents.
IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.
The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.
A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.
In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.